Yale University Medical Center

New Haven, Connecticut 06520

We've found

2 trials

at this facility

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

Status: Enrolling, Phase III
Updated: 12/31/1969

from

New Haven, CT

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Status: Upcoming, Phase IV
Updated: 9/15/2015

from

New Haven, CT

Use our guide to learn which trials are right for you!